{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T15:13:07Z","timestamp":1784733187093,"version":"3.55.0"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,6,5]],"date-time":"2025-06-05T00:00:00Z","timestamp":1749081600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,6,5]],"date-time":"2025-06-05T00:00:00Z","timestamp":1749081600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-04875-8","type":"journal-article","created":{"date-parts":[[2025,6,5]],"date-time":"2025-06-05T09:01:32Z","timestamp":1749114092000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Total cholesterol\/high-density lipoprotein cholesterol ratio is a candidate predictor of survival outcomes in patients with metastatic renal cell carcinoma"],"prefix":"10.1038","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3540-0701","authenticated-orcid":false,"given":"Oktay Halit","family":"Aktepe","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ozge","family":"Yetginoglu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehmet Sinan","family":"Akarca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Canberk","family":"Sencan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmet","family":"Unal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elif","family":"Atag","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huseyin Salih","family":"Semiz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aziz","family":"Karaoglu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mustafa","family":"Erman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suayib","family":"Yalcin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,6,5]]},"reference":[{"key":"4875_CR1","doi-asserted-by":"publisher","first-page":"394","DOI":"10.3322\/caac.21492","volume":"68","author":"F Bray","year":"2018","unstructured":"Bray, F. et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin. 68, 394\u2013424 (2018).","journal-title":"CA Cancer J. Clin."},{"key":"4875_CR2","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.semcancer.2012.06.004","volume":"23","author":"R Fisher","year":"2013","unstructured":"Fisher, R., Gore, M. & Larkin, J. Current and future systemic treatments for renal cell carcinoma. Semin Cancer Biol. 23, 38\u201345 (2013).","journal-title":"Semin Cancer Biol."},{"key":"4875_CR3","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/S0147-0272(97)80007-4","volume":"21","author":"RJ Motzer","year":"1997","unstructured":"Motzer, R. J., Russo, P., Nanus, D. M. & Berg, W. J. Renal cell carcinoma. Curr. Probl. Cancer. 21, 185\u2013232 (1997).","journal-title":"Curr. Probl. Cancer"},{"key":"4875_CR4","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21387","volume":"67","author":"RL Siegel","year":"2017","unstructured":"Siegel, R. L., Miller, K. D. & Jemal, A. Cancer statistics, 2017. CA Cancer J. Clin. 67, 7\u201330 (2017).","journal-title":"CA Cancer J. Clin."},{"key":"4875_CR5","doi-asserted-by":"publisher","first-page":"5794","DOI":"10.1200\/JCO.2008.21.4809","volume":"27","author":"DYC Heng","year":"2009","unstructured":"Heng, D. Y. C. et al. Prognostic factors for overall survival in patients with metastatic renal cell carcinoma treated with vascular endothelial growth factor\u2013targeted agents: results from a large, multicenter study. J. Clin. Oncol. 27, 5794\u20135799 (2009).","journal-title":"J. Clin. Oncol."},{"key":"4875_CR6","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1038\/nrc1408","volume":"4","author":"EE Calle","year":"2004","unstructured":"Calle, E. E. & Kaaks, R. Overweight, obesity and cancer: epidemiological evidence and proposed mechanisms. Nat. Rev. Cancer. 4, 579\u2013591 (2004).","journal-title":"Nat. Rev. Cancer"},{"key":"4875_CR7","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1097\/PPO.0b013e3181867628","volume":"14","author":"WH Chow","year":"2008","unstructured":"Chow, W. H. & Devesa, S. S. Contemporary epidemiology of renal cell cancer. Cancer J. 14, 288\u2013301 (2008).","journal-title":"Cancer J."},{"key":"4875_CR8","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1016\/j.bbagen.2014.11.004","volume":"1850","author":"S Hashmi","year":"2015","unstructured":"Hashmi, S. et al. Human cancer: is it linked to dysfunctional lipid metabolism? Biochim. Et Biophys. Acta (BBA) - Gen. Subj. 1850, 352\u2013364 (2015).","journal-title":"Biochim. Et Biophys. Acta (BBA) - Gen. Subj."},{"key":"4875_CR9","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.cca.2017.11.039","volume":"477","author":"P Zhou","year":"2018","unstructured":"Zhou, P., Li, B., Liu, B., Chen, T. & Xiao, J. Prognostic role of serum total cholesterol and high-density lipoprotein cholesterol in cancer survivors: A systematic review and meta-analysis. Clin. Chim. Acta. 477, 94\u2013104 (2018).","journal-title":"Clin. Chim. Acta"},{"key":"4875_CR10","doi-asserted-by":"publisher","first-page":"3188","DOI":"10.1158\/1078-0432.CCR-11-3137","volume":"18","author":"CK Lee","year":"2012","unstructured":"Lee, C. K. et al. Increase in cholesterol predicts survival advantage in renal cell carcinoma patients treated with Temsirolimus. Clin. Cancer Res. 18, 3188\u20133196 (2012).","journal-title":"Clin. Cancer Res."},{"key":"4875_CR11","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1186\/s12885-017-3322-5","volume":"17","author":"H Lee","year":"2017","unstructured":"Lee, H. et al. Preoperative cholesterol level as a new independent predictive factor of survival in patients with metastatic renal cell carcinoma treated with cyto-reductive nephrectomy. BMC Cancer. 17, 364 (2017).","journal-title":"BMC Cancer"},{"key":"4875_CR12","doi-asserted-by":"publisher","first-page":"984","DOI":"10.1054\/bjoc.2001.2040","volume":"85","author":"A Bergstr\u00f6m","year":"2001","unstructured":"Bergstr\u00f6m, A. et al. Obesity and renal cell cancer \u2013 a quantitative review. Br. J. Cancer. 85, 984\u2013990 (2001).","journal-title":"Br. J. Cancer"},{"key":"4875_CR13","doi-asserted-by":"publisher","first-page":"1523","DOI":"10.1001\/jama.282.16.1523","volume":"282","author":"A Must","year":"1999","unstructured":"Must, A. The disease burden associated with overweight and obesity. JAMA 282, 1523 (1999).","journal-title":"JAMA"},{"key":"4875_CR14","doi-asserted-by":"crossref","unstructured":"Nishida, A. & Andoh, A. The role of inflammation in cancer: mechanisms of tumor initiation, progression, and metastasis. Cells. 14, (2025).","DOI":"10.3390\/cells14070488"},{"key":"4875_CR15","doi-asserted-by":"publisher","first-page":"853","DOI":"10.3390\/jcm8060853","volume":"8","author":"L Ced\u00f3","year":"2019","unstructured":"Ced\u00f3, L., Reddy, S. T., Mato, E., Blanco-Vaca, F. & Escol\u00e0-Gil, J. C. HDL and LDL: potential new players in breast cancer development. J. Clin. Med. 8, 853 (2019).","journal-title":"J. Clin. Med."},{"key":"4875_CR16","doi-asserted-by":"publisher","first-page":"114654","DOI":"10.1016\/j.bcp.2021.114654","volume":"196","author":"KK Patel","year":"2022","unstructured":"Patel, K. K. & Kashfi, K. Lipoproteins and cancer: the role of HDL-C, LDL-C, and cholesterol-lowering drugs. Biochem. Pharmacol. 196, 114654 (2022).","journal-title":"Biochem. Pharmacol."},{"key":"4875_CR17","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.canlet.2016.11.033","volume":"388","author":"CW Lu","year":"2017","unstructured":"Lu, C. W. et al. VLDL and LDL, but not HDL, promote breast cancer cell proliferation, metastasis and angiogenesis. Cancer Lett. 388, 130\u2013138 (2017).","journal-title":"Cancer Lett."},{"key":"4875_CR18","doi-asserted-by":"publisher","first-page":"1311","DOI":"10.1158\/1535-7163.MCT-11-0905","volume":"11","author":"F Su","year":"2012","unstructured":"Su, F. et al. HDL mimetics inhibit tumor development in both induced and spontaneous mouse models of colon cancer. Mol. Cancer Ther. 11, 1311\u20131319 (2012).","journal-title":"Mol. Cancer Ther."},{"key":"4875_CR19","doi-asserted-by":"publisher","first-page":"7853","DOI":"10.1002\/jcp.30412","volume":"236","author":"T Zhao","year":"2021","unstructured":"Zhao, T. et al. Targeting HDL in tumor microenvironment: new hope for cancer therapy. J. Cell. Physiol. 236, 7853\u20137873 (2021).","journal-title":"J. Cell. Physiol."},{"key":"4875_CR20","doi-asserted-by":"publisher","first-page":"e74676","DOI":"10.1371\/journal.pone.0074676","volume":"8","author":"M Sanson","year":"2013","unstructured":"Sanson, M., Distel, E. & Fisher, E. A. HDL induces the expression of the M2 macrophage markers arginase 1 and Fizz-1 in a STAT6-dependent process. PLoS One. 8, e74676 (2013).","journal-title":"PLoS One"},{"key":"4875_CR21","doi-asserted-by":"crossref","unstructured":"Cruz, P. M. R., Mo, H., McConathy, W. J., Sabnis, N. & Lacko, A. G. The role of cholesterol metabolism and cholesterol transport in carcinogenesis: a review of scientific findings, relevant to future cancer therapeutics. Front. Pharmacol. 4, (2013).","DOI":"10.3389\/fphar.2013.00119"},{"key":"4875_CR22","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1016\/j.freeradbiomed.2006.07.006","volume":"41","author":"A Negre-Salvayre","year":"2006","unstructured":"Negre-Salvayre, A. et al. Antioxidant and cytoprotective properties of high-density lipoproteins in vascular cells. Free Radic Biol. Med. 41, 1031\u20131040 (2006).","journal-title":"Free Radic Biol. Med."},{"key":"4875_CR23","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.clnu.2004.08.004","volume":"24","author":"E Esteve","year":"2005","unstructured":"Esteve, E., Ricart, W. & Fern\u00e1ndez-Real, J. M. Dyslipidemia and inflammation: an evolutionary conserved mechanism. Clin. Nutr. 24, 16\u201331 (2005).","journal-title":"Clin. Nutr."},{"key":"4875_CR24","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1097\/MOL.0b013e328355ca25","volume":"23","author":"H Soran","year":"2012","unstructured":"Soran, H., Hama, S., Yadav, R. & Durrington, P. N. HDL functionality. Curr. Opin. Lipidol. 23, 353\u2013366 (2012).","journal-title":"Curr. Opin. Lipidol."},{"key":"4875_CR25","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1097\/00075197-200503000-00007","volume":"8","author":"A von Eckardstein","year":"2005","unstructured":"von Eckardstein, A., Hersberger, M. & Rohrer, L. Current understanding of the metabolism and biological actions of HDL. Curr. Opin. Clin. Nutr. Metab. Care. 8, 147\u2013152 (2005).","journal-title":"Curr. Opin. Clin. Nutr. Metab. Care"},{"key":"4875_CR26","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1186\/s12944-016-0225-4","volume":"15","author":"VG Flote","year":"2016","unstructured":"Flote, V. G. et al. Lipoprotein subfractions by nuclear magnetic resonance are associated with tumor characteristics in breast cancer. Lipids Health Dis. 15, 56 (2016).","journal-title":"Lipids Health Dis."},{"key":"4875_CR27","doi-asserted-by":"publisher","first-page":"3470","DOI":"10.1158\/0008-5472.CAN-12-4524-T","volume":"73","author":"ZC Hartman","year":"2013","unstructured":"Hartman, Z. C. et al. Growth of triple-negative breast cancer cells relies upon coordinate autocrine expression of the proinflammatory cytokines IL-6 and IL-8. Cancer Res. 73, 3470\u20133480 (2013).","journal-title":"Cancer Res."},{"key":"4875_CR28","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1007\/s005990070013","volume":"30","author":"AM Fiorenza","year":"2000","unstructured":"Fiorenza, A. M., Branchi, A. & Sommariva, D. Serum lipoprotein profile in patients with cancer. A comparison with non-cancer subjects. Int. J. Clin. Lab. Res. 30, 141\u2013145 (2000).","journal-title":"Int. J. Clin. Lab. Res."},{"key":"4875_CR29","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1093\/cvr\/cvv104","volume":"106","author":"JTM Tan","year":"2015","unstructured":"Tan, J. T. M., Ng, M. K. C. & Bursill, C. A. The role of high-density lipoproteins in the regulation of angiogenesis. Cardiovasc. Res. 106, 184\u2013193 (2015).","journal-title":"Cardiovasc. Res."},{"key":"4875_CR30","doi-asserted-by":"publisher","first-page":"1259","DOI":"10.1007\/s10552-008-9197-7","volume":"19","author":"L Magura","year":"2008","unstructured":"Magura, L. et al. Hypercholesterolemia and prostate cancer: a hospital-based case\u2013control study. Cancer Causes Control. 19, 1259\u20131266 (2008).","journal-title":"Cancer Causes Control"},{"key":"4875_CR31","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1016\/j.lungcan.2008.01.015","volume":"61","author":"AM Kucharska-Newton","year":"2008","unstructured":"Kucharska-Newton, A. M. et al. HDL-cholesterol and the incidence of lung cancer in the atherosclerosis risk in communities (ARIC) study. Lung Cancer. 61, 292\u2013300 (2008).","journal-title":"Lung Cancer"},{"key":"4875_CR32","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1093\/aje\/kwj253","volume":"164","author":"K Bowers","year":"2006","unstructured":"Bowers, K. et al. A prospective study of anthropometric and clinical measurements associated with insulin resistance syndrome and colorectal cancer in male smokers. Am. J. Epidemiol. 164, 652\u2013664 (2006).","journal-title":"Am. J. Epidemiol."},{"key":"4875_CR33","doi-asserted-by":"crossref","unstructured":"Chang, S. J. et al. The association between lipid profiles and breast cancer among Taiwanese women. Clin. Chem. Lab. Med. 45, (2007).","DOI":"10.1515\/CCLM.2007.263"},{"key":"4875_CR34","doi-asserted-by":"publisher","first-page":"1592","DOI":"10.1200\/JCO.2010.31.5200","volume":"29","author":"CM Kitahara","year":"2011","unstructured":"Kitahara, C. M. et al. Total cholesterol and cancer risk in a large prospective study in Korea. J. Clin. Oncol. 29, 1592\u20131598 (2011).","journal-title":"J. Clin. Oncol."},{"key":"4875_CR35","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1016\/j.ajpath.2010.11.005","volume":"178","author":"G Llaverias","year":"2011","unstructured":"Llaverias, G. et al. Role of cholesterol in the development and progression of breast cancer. Am. J. Pathol. 178, 402\u2013412 (2011).","journal-title":"Am. J. Pathol."},{"key":"4875_CR36","doi-asserted-by":"publisher","first-page":"e91080","DOI":"10.1371\/journal.pone.0091080","volume":"9","author":"PD Chi","year":"2014","unstructured":"Chi, P. D. et al. High-density lipoprotein cholesterol is a favorable prognostic factor and negatively correlated with C-reactive protein level in non-small cell lung carcinoma. PLoS One. 9, e91080 (2014).","journal-title":"PLoS One"},{"key":"4875_CR37","doi-asserted-by":"publisher","first-page":"101725","DOI":"10.1016\/j.canep.2020.101725","volume":"66","author":"KD Brantley","year":"2020","unstructured":"Brantley, K. D. et al. The association of serum lipid levels with colorectal cancer recurrence. Cancer Epidemiol. 66, 101725 (2020).","journal-title":"Cancer Epidemiol."},{"key":"4875_CR38","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1177\/1724600819831404","volume":"34","author":"B Hao","year":"2019","unstructured":"Hao, B. et al. Preoperative serum high-density lipoprotein cholesterol as a predictor of poor survival in patients with clear cell renal cell cancer. Int. J. Biol. Markers. 34, 168\u2013175 (2019).","journal-title":"Int. J. Biol. Markers"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-04875-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-04875-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-04875-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,5]],"date-time":"2025-06-05T09:01:34Z","timestamp":1749114094000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-04875-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,5]]},"references-count":38,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["4875"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-04875-8","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,5]]},"assertion":[{"value":"7 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 June 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This retrospective study involving human participants was reviewed and approved, and the need for informed consent was waived by the Ethic Commission of Hacettepe University (decision no: 2021\/05\u201323).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"19758"}}